Abstract
Objective
To examine effects of long-term topical anti-glaucoma medications on meibomian gland morphology and function and assess their relationship with slit-lamp findings.
Methods
This was a cross-sectional observational case series of 31 patients with glaucoma (mean age ± standard deviation, 65.0 ± 13.0 years; mean duration of eye drop use, 7.9 ± 6.0 years) treated with topical anti-glaucoma drugs in only one eye for more than 1 year: 13 receiving prostaglandin analogues (PGs) alone, eight receiving β-blockers alone, and ten receiving multiple treatments. Untreated contralateral eyes served as controls. Lid margin (lid margin abnormality score: 0–4) and superficial punctate keratopathy (SPK score: 0–1) were observed with a slit lamp. Upper and lower eyelids were turned over to observe meibomian glands using non-contact meibography. Meibomian gland loss was scored for each eyelid from grade 0 (no loss of meibomian glands) through grade 3 (loss >2/3 of total meibomian gland area). Meibomian lipid content (meibum) was scored (meibum score: 0–3).
Results
Treated eyes had significantly higher scores for lid margin abnormality (P = 0.001), SPK (P < 0.001), meibo-score (P < 0.001), and meibum (P < 0.001) than control eyes. Tear film break-up time (BUT) was significantly shorter in treated eyes than in control eyes (P = 0.001). Schirmer values were significantly lower in treated eyes than in control eyes (P = 0.0039). Subgroup analysis indicated a significantly higher meibo-score in eyes treated with PGs (P = 0.0046) and in eyes treated with β-blockers (P = 0.0231) than in the corresponding controls.
Conclusions
Long-term anti-glaucoma eye drop use affects meibomian gland morphology and function.
Similar content being viewed by others
References
Van Buskirk EM (1979) Corneal anesthesia after timolol maleate therapy. Am J Ophthalmol 88(4):739–743
Van Buskirk EM (1980) Adverse reactions from timolol administration. Ophthalmology 87(5):447–450
Weissman SS, Asbell PA (1990) Effects of topical timolol (0.5%) and betaxolol (0.5%) on corneal sensitivity. Br J Ophthalmol 74(7):409–412
Wilson RP, Spaeth GL, Effie P (1980) The place of timolol in the practice of ophthalmology. Ophthalmology 87:451–454
Alm A, Stjernschantz J (1995) The Scandinavian latanoprost study group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. Ophthalmology 102:1743–1752
Watson P, Stjernschantz J (1996) The latanoprost study group. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 103:126–137
Camras CB (1996) The United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. Ophthalmology 103:138–147
Kuppens EVMJ, Stolwijk TR, de Keizer RJW, van Best JA (1992) Basal tear turnover and topical timolol in glaucoma patients and healthy controls by fluorophotometry. Invest Ophthalmol Vis Sci 33:3442–3448
Herreras JM, Pastor JC, Calonge M, Asensio VM (1992) Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology 99:1082–1088
Arici MK, Arici DS, Topalkara A, Güler C (2000) Adverse effects of topical anti-glaucoma drugs on the ocular surface. Clin Exp Ophthalmol 28:113–117
Thygesen J, Aaen K, Theodorsen F, Kessing SV, Prause JU (2000) Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular hypertension. Acta Ophthalmol Scand 78:37–41
Sherwood MB, Grierson I, Millar L, Hitchings RA (1989) Long-term morphologic effects of antiglaucomatous drugs on the conjunctiva and Tenon’s capsule in glaucoma patients. Ophthalmology 96:327–335
Baudouin C, Garcher C, Haouat N, Bron A, Gastaud P (1994) Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma. Ophthalmology 101(3):454–460
Baudouin C, Liang H, Hamard P, Riancho L, Creuzot-Garcher C, Warnet JM, Brignole-Baudouin F (2008) The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology 115(1):109–115
Sharif NA, Kelly CR, Crider JY, Williams GW, Xu SX (2003) Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. J Ocul Pharmacol Ther 19(6):501–515
Ota T, Murata H, Sugimoto E, Aihara M, Araie M (2005) Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation. Invest Ophthalmol Vis Sci 46(6):2006–2011
Burstein NL (1985) The effects of topical drugs and preservatives on the tears and corneal epithelium in dry eye. Trans Ophthalmol Soc UK 104:402–409
Baudouin C, de Lunardo C (1998) Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br J Ophthalmol 82(1):39–42
Norm MS, Opauszki A (1977) Effects of ophthalmic vehicles on the stability of the precorneal tear film. Acta Ophthalmol 55:23–32
Yalvaç IS, Gedikoğlu G, Karagöz Y, Akgün U, Nurözler A, Koç F, Kasim R, Duman S (1995) Effects of antiglaucoma drugs on ocular surface. Acta Ophthalmol Scand 73(3):246–248
Kuppens EV, van Best JA, Sterk CC, de Keizer RJ (1995) Decreased basal tear turnover in patients with untreated primary open-angle glaucoma. Am J Ophthalmol 120(1):41–46
Kuppens EV, de Jong CA, Stolwijk TR, de Keizer RJ, van Best JA (1995) Effect of timolol with and without preservative on the basal tear turnover in glaucoma. Br J Ophthalmol 79(4):339–342
Wilson WS, Duncan AJ, Jay JL (1975) Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man. Br J Ophthalmol 59:667–669
Arita R, Itoh K, Inoue K, Amano S (2008) Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology 115:911–915
Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K (1998) Meibomian gland dysfunction in patients with Sjogren syndrome. Ophthalmol 105:1485–1488
Leung EW, Medeiros FA, Weinreb RN (2008) Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 17(5):350–355
Inoue K, Okugawa K, Kato S, Inoue Y, Tomita G, Oshika T, Amano S (2003) Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy. J Glaucoma 12(6):480–485
Brandt JD, Wittpenn JR, Katz LJ, Steinmann WN, Spaeth GL (1991) Conjunctival impression cytology in patients with glaucoma using long-term topical medication. Am J Ophthalmol 112(3):297–301
Broadway DC, Grierson I, O’Brien C, Hitchings RA (1994) Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol 112(11):1437–1445
Baudouin C, de Lunardo C (1998) Short term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br J Ophthalmol 82:39–42
Jester JV, Nicolaides N, Smith R (1981) Meibomian gland studies: histologic and ultrastructural investigations. Invest Ophthalmol Vis Sci 20:537–547
Nicolaides N, Santos EC, Smith RE, Jester JV (1989) Meibomian gland dysfunction, III: meibomian gland lipids. Invest Ophthalmol Vis Sci 30:946–951
Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Tomidokoro A, Amano S (2010) Meibomian gland duct distortion in patients with perennial allergic conjunctivitis. Cornea 29:858–860
Burstein NL (1980) Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas. Invest Ophthalmol Vis Sci 19(3):308–313
Pauly A, Meloni M, Baudouin FB, Warnet JM, Baudouin C (2009) Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage. Invest Ophthalmol Vis Sci 50(4):1644–1652
Ishibashi T, Yokoi N, Kinoshita S (2003) Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. J Glaucoma 12(6):486–490
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have no commercial or proprietary interest in the products or companies mentioned in the current article.
Rights and permissions
About this article
Cite this article
Arita, R., Itoh, K., Maeda, S. et al. Effects of long-term topical anti-glaucoma medications on meibomian glands. Graefes Arch Clin Exp Ophthalmol 250, 1181–1185 (2012). https://doi.org/10.1007/s00417-012-1943-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-012-1943-6